A campaign is ready in April. The creative is signed off, the channels are booked, the field is waiting. It goes live in June. The eight weeks in between are eaten by three rounds with the medical, legal and regulatory review. The easy reading is that the review is slow. The records usually say something quieter.
MLR is the gate every promotional material passes before it reaches a doctor. Medical checks the science. Legal and regulatory check the claims and the code. The intent is sound, and the gate protects the brand as much as the patient. The frustration is the number of times the same material goes through it.
Why a Collateral Stalls
The cause is usually a series of small problems, found one layer at a time. A reference missing on page four. Abbreviated prescribing information absent. A claim a shade beyond the approved label. An image that says a little more than the data does. Each round surfaces a new layer, because the first submission was, in honesty, a first draft. The reviewers are simply reading a draft that had not yet been read with their eyes.
That is where the time goes, and it is also where the time can be recovered. The approval clock starts at submission. The number of rounds is set earlier, by how close the first submission already is to the last.
The Read That Changes the Number
A structured read before submission changes that number. It is a read by the brand team, done before the file is sent, against the same dimensions the review will use. Are the claims referenced. Is the prescribing information present. Does any line run past the label. Does the visual overstate. It does not replace MLR. The final decision stays with the qualified review team. It moves the findings that would otherwise come back as round two onto the brand team's own desk, where they are cheap.
What It Does to the Room
When medico-marketing opens a collateral that has already been read against their criteria, the meeting shifts from correction to confirmation. Their time goes to the genuine judgement calls, the claim that needs a senior view, the nuance the brand team could not settle. It stops going to catching a missing reference for the third time. The quiet friction that often runs between the two sides, brand pushing for speed, medico holding the line, eases, because both are now working on cleaner material.
The Part in Your Hands
For the brand manager, this is the part of the timeline that is actually in your hands. The review team's pace is theirs. The quality of what you hand them is yours. A first submission that has already survived one honest read is a shorter path to the field, and a calmer one.
The habit is to treat the first submission as though it were the last. Read the collateral once, slowly, the way the reviewer will, before it ever reaches the reviewer. Most of the weeks lost to MLR are lost before MLR has seen the file.
Disclaimer: This is a practitioner view for brand teams. The final review and approval always sits with your medical, legal and regulatory team.